Literature DB >> 6365565

Dual radionuclide subtraction imaging of vertebral disc infection using an 111In-labelled leucocyte scan and a 99mTc-tin colloid scan.

P J Mountford, A J Coakley, F M Hall, C P Wells.   

Abstract

Interpretation of the posterior view of an 111In-labelled leucocyte scan is difficult when infection is suspected in that region of the spine overlaid by the left lobe of the liver. A case is reported of the successful localisation of infection in this region by combining an 111In-labelled leucocyte scan with a 99mTc-tin colloid scan in a dual radionuclide subtraction technique.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6365565     DOI: 10.1007/bf00251622

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  4 in total

1.  Computerized double-tracer subtraction scanning with gallium-67 citrate in inflammatory diseases.

Authors:  V M Dhawan; J J Sziklas; R P Spencer; D A Rich
Journal:  J Nucl Med       Date:  1978-12       Impact factor: 10.057

2.  111In-labelled leucocyte and 99mTc-methylene diphosphonate bone scanning in pelvic osteomyelitis.

Authors:  F M Hall; M E Conybeare; A J Coakley; P J Mountford; C P Wells
Journal:  Eur J Nucl Med       Date:  1983

3.  Indium-111-labeled autologous leukocytes in man.

Authors:  M L Thakur; J P Lavender; R N Arnot; D J Silvester; A W Segal
Journal:  J Nucl Med       Date:  1977-10       Impact factor: 10.057

4.  Differentiating hepatic abscess from tumor: combined 111In white blood cell and 99mTc liver scans.

Authors:  H D Fawcett; R L Lantieri; A Frankel; I R McDougall
Journal:  AJR Am J Roentgenol       Date:  1980-07       Impact factor: 3.959

  4 in total
  2 in total

1.  Indium-111 leucocyte scanning--underused?

Authors:  A J Coakley; P J Mountford
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-18

2.  (99m)tc-Ubiquicidin [29-41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation.

Authors:  Davood Beiki; Gholamali Yousefi; Babak Fallahi; Mohammad Naghi Tahmasebi; Ali Gholamrezanezhad; Armaghan Fard-Esfahani; Mostafa Erfani; Mohammad Eftekhari
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.